Funded Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Initiative	Program Official
Yang, Qing	University Of Texas Med Br Galveston United States	The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy	1R01CA273001-01A1		Rachel Altshuler, Ph.D.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-03		Eileen Dimond, R.N., M.S.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future	5R01CA227576-05		Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna	Roswell Park Cancer Institute Corp United States	Metformin for chemoprevention of lung cancer in obese subjects at high risk	3R01CA255515-04S1		Eva Szabo, M.D.
Yilmaz, Omer	Massachusetts Institute Of Technology United States	PROSPECT - Stem cell models	1OT2CA297570-01		Asad Umar, D.V.M., Ph.D.
Yost, Kathleen J	Corewell Health United States	Cancer Research Consortium of West Michigan (CRCWM)	5UG1CA189860-11		Vanessa A. White, M.P.H.
You, Ming	Methodist Hospital Research Institute United States	Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis	5R01CA280746-02		John Clifford, Ph.D.
You, Ming	Methodist Hospital Research Institute United States	Chemoprevention of lung cancer by targeting lonidamine to mitochondria	5R01CA232433-05		John Clifford, Ph.D.
Young, Steven L	Duke University United States	Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis	5P01HD106485-04		Goli Samimi, Ph.D., M.P.H.
Yu, Dihua	University Of Tx Md Anderson Can Ctr United States	Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer	5R01CA270010-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Marjorie Perloff, M.D.